Cargando…

Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys

BACKGROUND: To determine where interventions are needed to eliminate trachoma as a public health problem, prevalence data are needed. We aimed to generate baseline population-based data on trachoma prevalence in suspected-endemic areas of Afghanistan. METHODS: Cross-sectional population-based preval...

Descripción completa

Detalles Bibliográficos
Autores principales: Salam, Ahmad Shah, Qayumi, Rafiqullah, Majeed Siddiqi, Abdul, Naseem, Mohammad, Mansoor, Mirwais, Butcher, Robert, Bakhtiari, Ana, Renneker, Kristen, Willis, Rebecca, Jimenez, Cristina, Dejene, Michael, Safi, Naimullah, Heggen, Anne, Solomon, Anthony W., Harding-Esch, Emma M., Alizoi, Najeebullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581673/
https://www.ncbi.nlm.nih.gov/pubmed/35272540
http://dx.doi.org/10.1080/09286586.2021.2015784
_version_ 1785122185312993280
author Salam, Ahmad Shah
Qayumi, Rafiqullah
Majeed Siddiqi, Abdul
Naseem, Mohammad
Mansoor, Mirwais
Butcher, Robert
Bakhtiari, Ana
Renneker, Kristen
Willis, Rebecca
Jimenez, Cristina
Dejene, Michael
Safi, Naimullah
Heggen, Anne
Solomon, Anthony W.
Harding-Esch, Emma M.
Alizoi, Najeebullah
author_facet Salam, Ahmad Shah
Qayumi, Rafiqullah
Majeed Siddiqi, Abdul
Naseem, Mohammad
Mansoor, Mirwais
Butcher, Robert
Bakhtiari, Ana
Renneker, Kristen
Willis, Rebecca
Jimenez, Cristina
Dejene, Michael
Safi, Naimullah
Heggen, Anne
Solomon, Anthony W.
Harding-Esch, Emma M.
Alizoi, Najeebullah
author_sort Salam, Ahmad Shah
collection PubMed
description BACKGROUND: To determine where interventions are needed to eliminate trachoma as a public health problem, prevalence data are needed. We aimed to generate baseline population-based data on trachoma prevalence in suspected-endemic areas of Afghanistan. METHODS: Cross-sectional population-based prevalence surveys designed according to World Health Organization (WHO) recommendations were conducted in 35 evaluation units (EUs) covering 72 districts. In selected households, all resident individuals aged ≥1 year were examined for trachomatous inflammation—follicular (TF) and trachomatous trichiasis (TT) according to the WHO simplified trachoma grading system. Water, sanitation and hygiene access was assessed in households of survey participants. RESULTS: 104,104 people aged ≥1 year were examined, including 43,774 children aged 1–9 years and 46,439 people aged ≥15 years. The age-adjusted prevalence of TF in 1–9-year-olds was ≥5% in 3 EUs, with the highest EU TF prevalence being 7.8%. The age- and gender-adjusted prevalence of TT unknown to the health system in ≥15-year-olds was <0.2% in all EUs. The majority of households had access to an improved water source within 30 minutes of the house. However, only a minority of households had an improved latrine and/or a handwash station. CONCLUSIONS: Trachoma is not a public health problem in the majority of EUs surveyed. However, antibiotic mass drug administration, promotion of facial cleanliness and environmental improvement (the A, F and E components of the SAFE strategy) are needed for trachoma elimination purposes in three of the EUs surveyed in Afghanistan.
format Online
Article
Text
id pubmed-10581673
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-105816732023-10-18 Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys Salam, Ahmad Shah Qayumi, Rafiqullah Majeed Siddiqi, Abdul Naseem, Mohammad Mansoor, Mirwais Butcher, Robert Bakhtiari, Ana Renneker, Kristen Willis, Rebecca Jimenez, Cristina Dejene, Michael Safi, Naimullah Heggen, Anne Solomon, Anthony W. Harding-Esch, Emma M. Alizoi, Najeebullah Ophthalmic Epidemiol Research Article BACKGROUND: To determine where interventions are needed to eliminate trachoma as a public health problem, prevalence data are needed. We aimed to generate baseline population-based data on trachoma prevalence in suspected-endemic areas of Afghanistan. METHODS: Cross-sectional population-based prevalence surveys designed according to World Health Organization (WHO) recommendations were conducted in 35 evaluation units (EUs) covering 72 districts. In selected households, all resident individuals aged ≥1 year were examined for trachomatous inflammation—follicular (TF) and trachomatous trichiasis (TT) according to the WHO simplified trachoma grading system. Water, sanitation and hygiene access was assessed in households of survey participants. RESULTS: 104,104 people aged ≥1 year were examined, including 43,774 children aged 1–9 years and 46,439 people aged ≥15 years. The age-adjusted prevalence of TF in 1–9-year-olds was ≥5% in 3 EUs, with the highest EU TF prevalence being 7.8%. The age- and gender-adjusted prevalence of TT unknown to the health system in ≥15-year-olds was <0.2% in all EUs. The majority of households had access to an improved water source within 30 minutes of the house. However, only a minority of households had an improved latrine and/or a handwash station. CONCLUSIONS: Trachoma is not a public health problem in the majority of EUs surveyed. However, antibiotic mass drug administration, promotion of facial cleanliness and environmental improvement (the A, F and E components of the SAFE strategy) are needed for trachoma elimination purposes in three of the EUs surveyed in Afghanistan. Taylor & Francis 2022-03-10 /pmc/articles/PMC10581673/ /pubmed/35272540 http://dx.doi.org/10.1080/09286586.2021.2015784 Text en © 2022 World Health Organization. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/3.0/igo/This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO License (https://creativecommons.org/licenses/by/3.0/igo/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that the World Health Organization (WHO) endorses any specific organization, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL. Disclaimer The authors are staff members of the World Health Organization and are themselves alone responsible for the views expressed in the Article, which do not necessarily represent the views, decisions, or policies of the World Health Organization or Taylor & Francis Group.
spellingShingle Research Article
Salam, Ahmad Shah
Qayumi, Rafiqullah
Majeed Siddiqi, Abdul
Naseem, Mohammad
Mansoor, Mirwais
Butcher, Robert
Bakhtiari, Ana
Renneker, Kristen
Willis, Rebecca
Jimenez, Cristina
Dejene, Michael
Safi, Naimullah
Heggen, Anne
Solomon, Anthony W.
Harding-Esch, Emma M.
Alizoi, Najeebullah
Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys
title Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys
title_full Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys
title_fullStr Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys
title_full_unstemmed Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys
title_short Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys
title_sort prevalence of trachoma in 72 districts of afghanistan in 2018−2019: results of 35 population-based prevalence surveys
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581673/
https://www.ncbi.nlm.nih.gov/pubmed/35272540
http://dx.doi.org/10.1080/09286586.2021.2015784
work_keys_str_mv AT salamahmadshah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT qayumirafiqullah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT majeedsiddiqiabdul prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT naseemmohammad prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT mansoormirwais prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT butcherrobert prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT bakhtiariana prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT rennekerkristen prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT willisrebecca prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT jimenezcristina prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT dejenemichael prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT safinaimullah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT heggenanne prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT solomonanthonyw prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT hardingeschemmam prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys
AT alizoinajeebullah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys